CALGARY, AB, March 4, 2021 /PRNewswire/ – MagicMed Industries Inc. (CSE: MGIC reserved) (“MagicMed” or the “Company“) announced today a collaboration among the Company, Dr. Suran Goonatilake and Dr. Eric Nyberg, renowned thought leaders in artificial intelligence (“AI“). Together the parties are building PsyAITM, a tool designed to provide comprehensive, pharmaceutical design, manufacturing…

Source

Previous articleRegulatory Approvals Place Numinus Lab at the Forefront of Global Psychedelics Research
Next articleTryp Therapeutics Announces Application to List on OTCQB